Literature DB >> 19753471

Morbidity and prognostic factors in chronic chagasic cardiopathy.

Manoel Otávio C Rocha1, Maria Carmo P Nunes, Antonio L Ribeiro.   

Abstract

Chagas disease is a pleomorphic clinical entity that has several unique features. The aim of this study is to summarise some of the recent contributions from our research group to knowledge of the morbidity and prognostic factors in Chagas heart disease. A retrospective study suggested that ischaemic stroke associated with left ventricular (LV) apical thrombi is the first clinical manifestation of Chagas disease observed in a large proportion of patients. LV function and left atrial volume (LAV) are independent risk factors for ischaemic cerebrovascular events during follow-up of Chagas heart disease patients. Pulmonary congestion in Chagas-related dilated cardiomyopathy is common but usually mild. Although early right ventricular (RV) involvement has been described, we have shown by Doppler echocardiography that RV dysfunction is evident almost exclusively when it is associated with left ventricle dilatation and functional impairment. In addition, RV dysfunction is a powerful predictor of survival in patients with heart failure secondary to Chagas disease. We have also demonstrated that LAV provides incremental prognostic information independent of clinical data and conventional echocardiographic parameters that predict survival.

Entities:  

Mesh:

Year:  2009        PMID: 19753471     DOI: 10.1590/s0074-02762009000900022

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  14 in total

1.  Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection.

Authors:  Maria A P Martins; Daniel D Ribeiro; Vandack A Nobre; Fabiana R Pereira; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2012-09-28       Impact factor: 2.953

Review 2.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

3.  IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection.

Authors:  Ester Roffê; Antonio Gigliotti Rothfuchs; Helton C Santiago; Ana Paula M P Marino; Flavia L Ribeiro-Gomes; Michael Eckhaus; Lis R V Antonelli; Philip M Murphy
Journal:  J Immunol       Date:  2011-12-12       Impact factor: 5.422

4.  Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting.

Authors:  Katherine R McAleese; Janitzio J Guzmán; Lauren Thumm; Thomas B Nutman; Adrienne Showler; Elise M O'Connell
Journal:  Clin Infect Dis       Date:  2022-09-14       Impact factor: 20.999

Review 5.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

6.  The centennial of the discovery of Chagas disease: facing the current challenges.

Authors:  Joseli Lannes-Vieira; Tania C de Araújo-Jorge; Maria de Nazaré Correia Soeiro; Paulo Gadelha; Rodrigo Corrêa-Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

7.  Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.

Authors:  Ester C Sabino; Antonio L Ribeiro; Vera M C Salemi; Claudia Di Lorenzo Oliveira; Andre P Antunes; Marcia M Menezes; Barbara M Ianni; Luciano Nastari; Fabio Fernandes; Giuseppina M Patavino; Vandana Sachdev; Ligia Capuani; Cesar de Almeida-Neto; Danielle M Carrick; David Wright; Katherine Kavounis; Thelma T Goncalez; Anna Barbara Carneiro-Proietti; Brian Custer; Michael P Busch; Edward L Murphy
Journal:  Circulation       Date:  2013-02-07       Impact factor: 29.690

8.  Clinical findings and prognosis of patients hospitalized for acute decompensated heart failure: Analysis of the influence of Chagas etiology and ventricular function.

Authors:  Caíque Bueno Terhoch; Henry Fukuda Moreira; Silvia Moreira Ayub-Ferreira; Germano Emilio Conceição-Souza; Vera Maria Cury Salemi; Paulo Roberto Chizzola; Mucio Tavares Oliveira; Silvia Helena Gelas Lage; Edimar Alcides Bocchi; Victor Sarli Issa
Journal:  PLoS Negl Trop Dis       Date:  2018-02-12

9.  The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function.

Authors:  Giovane R Sousa; Juliana A S Gomes; Marcos Paulo S Damasio; Maria Carmo P Nunes; Henrique S Costa; Nayara I Medeiros; Rafaelle C G Fares; Ana Thereza Chaves; Rodrigo Corrêa-Oliveira; Manoel Otávio C Rocha
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

10.  Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.

Authors:  Antonio L Ribeiro; Ester C Sabino; Milena S Marcolino; Vera M C Salemi; Barbara M Ianni; Fábio Fernandes; Luciano Nastari; André Antunes; Márcia Menezes; Cláudia Di Lorenzo Oliveira; Vandana Sachdev; Danielle M Carrick; Michael P Busch; Eduard L Murphy
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.